Prostate cancer risk check for Nigerian men
Part of Cancer, Kidney & urinary clinical trials.
This study tests a new way for doctors in community clinics to estimate prostate cancer risk in men aged 40 to 79. It aims to improve early detection and care in Nigeria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 40 and 79 years old.
- You visit a community-level hospital or clinic in Nigeria.
- You are able to talk with a healthcare provider about your health.
- You are not currently excluded by any other medical condition (none listed).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This project aims to learn about prostate cancer risk and screening needs in Black or African American adults. You may be asked questions and tested as part of determining who might benefit from prostate screening.
This trial looks at how inherited risk (family history or gene findings) relates to screening and treatment for prostate cancer. If you qualify, you may be offered prostate screening tests and follow-up to see how well risk information predicts next steps.
This trial studies whether a risk assessment can better predict who actually has prostate cancer based on information collected around the biopsy. It may help doctors decide what biopsy findings mean for people with certain PSA (a blood test) results.
This study tests a health education program to help men learn about prostate cancer and encourage them to get screened. It is a pilot study that will see if the program works, so it might help you understand your risk and take action for your health.
This trial offers free prostate cancer education and screening to Black men in Oklahoma who haven't been diagnosed yet. It aims to increase awareness and catch cancer early, but requires using a phone app for 30 days.
This trial aims to raise awareness and screen for prostate cancer in men aged 50 to 69 across the European Union. You may be able to join if you have never been diagnosed with prostate cancer and haven't had a prostate biopsy or MRI in the last six months.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.